This page includes the latest FDA filings for Takeda Pharmaceuticals U S A Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | myPKFiT for Patients Mobile Application | 2025-01-13 |
| Takeda Pharmaceuticals U.S.A., Inc. | myPKFiT for Healthcare Professionals | 2025-01-13 |
| Takeda Pharmaceuticals U.S.A., Inc. | BAXJECT II Hi-Flow | 2024-06-20 |
| Takeda Pharmaceuticals U.S.A., Inc. | BAXJECT II 6507816 | 2024-03-08 |
| Takeda Pharmaceuticals U.S.A., Inc. | Anti-Drug Antibody Biomarker Specimen Collection Kit 5000833 | 2023-11-07 |
| NCAGE Code | 7ERY5 | TAKEDA PHARMACEUTICALS U.S.A., INC |
| CAGE Code | 7ERY5 | TAKEDA PHARMACEUTICALS U.S.A., INC |
| SEC | 0001716229 | Takeda Pharmaceuticals U.S.A., Inc. of DELAWARE |